These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


263 related items for PubMed ID: 17762848

  • 21. Sensitivity and specificity of spinal inflammatory lesions assessed by whole-body magnetic resonance imaging in patients with ankylosing spondylitis or recent-onset inflammatory back pain.
    Weber U, Hodler J, Kubik RA, Rufibach K, Lambert RG, Kissling RO, Pfirrmann CW, Maksymowych WP.
    Arthritis Rheum; 2009 Jul 15; 61(7):900-8. PubMed ID: 19565558
    [Abstract] [Full Text] [Related]

  • 22. Persistent clinical efficacy and safety of anti-tumour necrosis factor alpha therapy with infliximab in patients with ankylosing spondylitis over 5 years: evidence for different types of response.
    Braun J, Baraliakos X, Listing J, Fritz C, Alten R, Burmester G, Krause A, Schewe S, Schneider M, Sörensen H, Zeidler H, Sieper J.
    Ann Rheum Dis; 2008 Mar 15; 67(3):340-5. PubMed ID: 17967831
    [Abstract] [Full Text] [Related]

  • 23. Development of a core set of domains for data collection in cohorts of patients with ankylosing spondylitis receiving anti-tumor necrosis factor-alpha therapy.
    Zochling J, Sieper J, van der Heijde D, Braun J, Assessment in Ankylosing Spondylitis International Working Group.
    J Rheumatol; 2008 Jun 15; 35(6):1079-82. PubMed ID: 18464306
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Trend towards increased arterial stiffness or intima-media thickness in ankylosing spondylitis patients without clinically evident cardiovascular disease.
    Mathieu S, Joly H, Baron G, Tournadre A, Dubost JJ, Ristori JM, Lusson JR, Soubrier M.
    Rheumatology (Oxford); 2008 Aug 15; 47(8):1203-7. PubMed ID: 18524805
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Can structural damage be prevented in ankylosing spondylitis?
    Sieper J.
    Curr Opin Rheumatol; 2009 Jul 15; 21(4):335-9. PubMed ID: 19424070
    [Abstract] [Full Text] [Related]

  • 28. [Follow-up of the patient with spondyloarthropathy].
    Dougados M.
    Ann Med Interne (Paris); 1998 Apr 15; 149(3):149-55. PubMed ID: 11490537
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. [Whipple's disease with normal duodenal histology and ankylosing spondylitis].
    Ahmadi-Simab K, Schnitzler P.
    Dtsch Med Wochenschr; 2009 Jan 15; 134(4):127-30. PubMed ID: 19148854
    [Abstract] [Full Text] [Related]

  • 31. Assessments in ankylosing spondylitis.
    Zochling J, Braun J, van der Heijde D.
    Best Pract Res Clin Rheumatol; 2006 Jun 15; 20(3):521-37. PubMed ID: 16777580
    [Abstract] [Full Text] [Related]

  • 32. [Clinical study of etanercept for treating ankylosing spondylitis].
    Liang LQ, Zhan ZP, Ye YJ, Fu D, Xu HS, Yang XY.
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Aug 15; 28(8):1349-51. PubMed ID: 18753057
    [Abstract] [Full Text] [Related]

  • 33. Magnetic resonance imaging assessment of spinal inflammation in patients treated for ankylosing spondylitis.
    Treitl M, Korner M, Becker-Gaab C, Tryzna M, Rieger J, Pfeifer KJ, Reiser MF, Wirth S.
    J Rheumatol; 2008 Jan 15; 35(1):126-36. PubMed ID: 18061979
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. [Clinical features of ankylosing spondylitis--epidemiologic study].
    Jajić Z, Grazio S, Nemcić T, Jajić I.
    Reumatizam; 1997 Jan 15; 45(2):13-8. PubMed ID: 9769723
    [Abstract] [Full Text] [Related]

  • 36. Immunogenicity does not influence treatment with etanercept in patients with ankylosing spondylitis.
    de Vries MK, van der Horst-Bruinsma IE, Nurmohamed MT, Aarden LA, Stapel SO, Peters MJ, van Denderen JC, Dijkmans BA, Wolbink GJ.
    Ann Rheum Dis; 2009 Apr 15; 68(4):531-5. PubMed ID: 18375542
    [Abstract] [Full Text] [Related]

  • 37. A case of axial undifferentiated spondyloarthritis diagnosis and management.
    Rudwaleit M, Sieper J.
    Nat Clin Pract Rheumatol; 2007 May 15; 3(5):298-303. PubMed ID: 17471249
    [Abstract] [Full Text] [Related]

  • 38. Evaluation of ankylosing spondylitis spinal mobility measurements in the assessment of spinal involvement in psoriatic arthritis.
    Fernández-Sueiro JL, Willisch A, Pértega-Díaz S, Tasende JA, Fernández-Lopez C, Galdo F, Blanco FJ.
    Arthritis Rheum; 2009 Mar 15; 61(3):386-92. PubMed ID: 19248134
    [Abstract] [Full Text] [Related]

  • 39. Thoracoabdominal motion in ankylosing spondylitis: association with standardised clinical measures and response to therapy.
    Tzelepis GE, Kalliakosta G, Tzioufas AG, Sfikakis PP, Mandros C, Boki KA, Roussos C, Moutsopoulos HM.
    Ann Rheum Dis; 2009 Jun 15; 68(6):966-71. PubMed ID: 18633126
    [Abstract] [Full Text] [Related]

  • 40. Inflammatory back pain in ankylosing spondylitis: a reassessment of the clinical history for application as classification and diagnostic criteria.
    Rudwaleit M, Metter A, Listing J, Sieper J, Braun J.
    Arthritis Rheum; 2006 Feb 15; 54(2):569-78. PubMed ID: 16447233
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 14.